advertising
-
2
Massing AM, Epstein WL: Natural history of warts. .Arch Dermatol 87::306. ,1963. .
-
3
Penneys N: “Diseases Caused by Viruses,” in Lever’s Histopathology of the Skin, 8th Ed, ed by D Elder, R Elenitasas, C Jaworsky, et al, p 578, Lippincott-Raven, Philadelphia. ,1997. .
-
4
Bunney MH: Viral Warts: Their Biology and Treatment, p 1, Oxford University Press, New York. ,1982. .
-
5
Johnson LW: Communal showers and the risk of plantar warts. .J Fam Pract 40::136. ,1995. .
-
6
Smotkin D: Virology of human papillomavirus. .Clin Obstet Gynecol 32::117. ,1989. .
-
7
Shelley WB, Shelley ED: Intralesional bleomycin sulfate therapy for warts: a novel bifurcated needle puncture technique. .Arch Dermatol 127::234. ,1991. .
-
8
Lasser AE, Glazer SD: Vehicle effects on comparative irritancy: a patient compliance in topical wart therapy. .Curr Ther Res 39::1011. ,1986. .
-
9
Fabbrocini G, Di Costanzo MP, Riccardo AM, et al: Photodynamic therapy with topical delta-aminolae-vulinic acid for the treatment of plantar warts. .J Photochem Photobiol B 61::30. ,2001. .
-
10
Buckley D: Cryosurgery treatment of plantar warts. .Ir Med J 93::140. ,2000. .
-
11
El-Tonsy MH, Anbar TE, El-Domyati M, et al: Density of viral particles in pre and post Nd: YAG laser hyperthermia therapy and cryotherapy in plantar warts. .Int J Dermatol 38::393. ,1999. .
-
12
Pollock B, Sheehan-Dare R: Pulsed dye laser and intralesional bleomycin for treatment of resistant viol hand warts. .Lasers Surg Med 30::135. ,2002. .
-
13
Manz LA, Pelachyk JM: Bleomycin-lidocaine mixture reduces pain of intralesional injection in the treatment of recalcitrant verrucae. .J Am Acad Dermatol 25::524. ,1991. .
-
14
Umezawa H: Chemistry and mechanism of action of bleomycin. .Fed Proc 33::2296. ,1974. .
-
15
Templeton SF, Solomon AR, Swerlick RA: Intradermal bleomycin injections into normal human skin. .Arch Dermatol 130::577. ,1994. .
-
16
Umezawa H, Maeda K, Takeuchi T, et al: New antibiotics, bleomycin A and B. .J Antibiot A 19::200. ,1966. .
-
17
Shumer SM, O’Keefe EJ: Bleomycin in the treatment of recalcitrant warts. .J Am Acad Dermatol 9::91. ,1983. .
-
18
Ichikawa T, Nakano I, Hirokawa I: Bleomycin treatment of the tumors of penis and scrotum. .J Urol 102::699. ,1969. .
-
19
Yagoda A, Mukherji B, Young C, et al: Bleomycin, an antitumor antibiotic. .Ann Intern Med 77::861. ,1972. .
-
20
James MP, Collier PM, Aherne W, et al: Histologic, pharmacologic, and immunocytochemical effects of injection of bleomycin into viral warts. .J Am Acad Dermatol 28::933. ,1993. .
-
21
Crooke ST, Bradner WT: Bleomycin: a review. .J Med 7::333. ,1977. .
-
22
Kuo MT, Haidle CW: Characterization of chain breakage in DNA induced by bleomycin. .Biochim Biopys Acta 335::109. ,1974. .
-
23
Bennett JM, Reich SD: Bleomycin. .Ann Intern Med 90::945. ,1979. .
-
24
Cordero AA, Guglielmi HA, Woscoff A: The common wart: intralesional treatment with bleomycin sulfate. .Cutis 26::319. ,1980. .
-
25
Olson RL: Plantar warts yield to DNA inhibitor. .JAMA 237::940. ,1977. .
-
26
Middleton RK, Chan S: Bleomycin treatment of warts. .DICP 24::952. ,1990. .
-
27
Miller R: Nail dystrophy following intralesional injections of bleomycin for a periungual wart [letter]. .Arch Dermatol 120::963. ,1984. .
-
28
Sollitto RJ, Pizzano DM: Bleomycin sulfate in the treatment of mosaic plantar verrucae: a follow-up study. .J Foot Ankle Surg 35::169. ,1996. .
-
29
Abbott LG: Treatment of warts with bleomycin. .Aust J Dermatol 19::67. ,1978. .
-
30
Amer M, Diab N, Ramadan A, et al: Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts. .J Am Acad Dermatol 18::1313. ,1988. .
-
31
Hall SW, Broughton A, Strong JE, et al: Clinical pharmacology of bleomycin by radio-immunoassay. .Clin Res 25::407. ,1977. .
-
32
Carter ST, Crooke ST, Umezawa H (eds): Bleomycin: Current Status and New Developments, Academic Press, New York. ,1978. .
-
33
Le Bouffant R, Cormier P, Mulner-Lorillon O, et al: Hypoxia and DNA-damaging agent bleomycin both increase the cellular level of the protein 4E-BP. J Cell Biochem [e-pub], April 5. ,2006. .
-
34
Meberg R, Kenyon E, Bierman R, et al: Characterization of plantar verrucae among individuals with human immunodeficiency virus. .JAPMA 88::442. ,1998. .
-
35
Kang S, Fitzpatrick T: Debilitating verruca vulgaris in a patient infected with the human immunodeficiency virus. .Arch Dermatol 130::294. ,1994. .
-
36
Barbosa P: Plantar verrucae and HIV infection. .Clin Podiatr Med Surg 15::317. ,1998. .
-
37
Memar O, Cirelli R, Lee P, et al: Cutaneous manifestations of HIV-1 infection. .JAPMA 85::362. ,1995. .
Intralesional Bleomycin Sulfate Injection for the Treatment of Verruca Plantaris
Search for other papers by Robert Salk in
Current site
Google Scholar
PubMed
Search for other papers by Troy S. Douglas in
Current site
Google Scholar
PubMed
Sixty-two patients were treated for single or multiple warts by intralesional injection of bleomycin sulfate (1.5 U/mL) and then were observed for 6 months. The dose varied according to the size of the lesion and ranged from 0.25 to 1.0 mL per injection per lesion, up to a maximum dose of 3 mL. The total cure rate was 87% after one or two injections. Twelve of the 62 patients required a second injection. (J Am Podiatr Med Assoc 96(3): 220–225, 2006)
advertising
advertising
